These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19389518)

  • 1. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
    Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
    J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
    Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
    Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R
    Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer].
    Ma Y; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):223-7. PubMed ID: 19462894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
    Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
    Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
    Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
    Bayer-Garner IB; Hough AJ; Smoller BR
    Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
    Depasquale I; Thompson WD
    Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
    Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of tumor angiogenesis with clinicopathologic prognostic parameters in choroidal melanoma].
    Wang FH; Li B; Sun XL; Li LQ; Chen CX
    Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):68-72. PubMed ID: 12783682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
    Shi L; Chen XM; Wang L; Zhang L; Chen Z
    Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance.
    Middleman BR; Friedman M; Lawson DH; DeRose PB; Cohen C
    Mod Pathol; 2002 May; 15(5):532-7. PubMed ID: 12011258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.
    Ali-Fehmi R; Morris RT; Bandyopadhyay S; Che M; Schimp V; Malone JM; Munkarah AR
    Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
    Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
    Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin expression and its clinical significance in non-small cell lung cancer.
    Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F
    Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.